Showing results (1091-1100 of 1,175) with videos related to

Sort By:
Pageof 118
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 23, 2014
Phase II randomized trial comparing sequential first-line everolimus and second-line sunitinib versus first-line sunitinib and second-line everolimus in patients with metastatic renal cell carcinomaRobert J Motzer, Carlos H Barrios, Tae Min Kim, et al.
MMWR. Morbidity and Mortality Weekly Report|November 30, 2023
SARS-CoV-2 Epidemiology and COVID-19 mRNA Vaccine Effectiveness Among Infants and Children Aged 6 Months-4 Years - New Vaccine Surveillance Network, United States, July 2022-September 2023Ayzsa Tannis, Janet A Englund, Ariana Perez, et al.
Eclinicalmedicine|April 30, 2024
Cost-effectiveness and budget impact of decentralising childhood tuberculosis diagnosis in six high tuberculosis incidence countries: a mathematical modelling studyMarc d'Elbée, Martin Harker, Nyashadzaishe Mafirakureva, et al.
Journal of Medical Microbiology|March 7, 2025
Impact of the COVID-19 pandemic on invasive pneumococcal disease in American Indian communities in the Southwest USCatherine G Sutcliffe, Shea Littlepage, Del Yazzie, et al.
Blood|December 17, 2013
Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762Aristeidis Chaidos, Valentina Caputo, Katerina Gouvedenou, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2023
Host interactions of novel Crassvirales species belonging to multiple families infecting bacterial host, Bacteroides cellulosilyticus WH2Bhavya Papudeshi, Alejandro A Vega, Cole Souza, et al.
Microbial Genomics|September 4, 2023
Host interactions of novel Crassvirales species belonging to multiple families infecting bacterial host, Bacteroides cellulosilyticus WH2Bhavya Papudeshi, Alejandro A Vega, Cole Souza, et al.
Physical Review Letters|November 17, 2018
Superallowed α Decay to Doubly Magic ^{100}SnK Auranen, D Seweryniak, M Albers, et al.
Science (New York, N.Y.)|August 9, 2020
The proteasome controls ESCRT-III-mediated cell division in an archaeonGabriel Tarrason Risa, Fredrik Hurtig, Sian Bray, et al.
Breast Cancer Research : BCR|March 15, 2019
PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trialStephen K L Chia, Miguel Martin, Frankie A Holmes, et al.
Pageof 118